Asthma: prevalence and cost of illness von Stock, S, Redaelli, M, Luengen, M, Wendland, G, Civello, D, Lauterbach, K. W

Volltext

Diabetes-prevalence and cost of illness in Germany: a study evaluating data from the statutory health insurance in Germany von Stock, S. A. K., Redaelli, M., Wendland, G., Civello, D., Lauterbach, K. W.

Volltext

Distortion reduction in cascaded slow light delays von SCHNEIDER, T, JUNKER, M, LAUTERBACH, K. U, HENKER, R

Volltext

A comparative test of Brillouin amplification and erbium-doped fiber amplification for the generation of millimeter waves with low phase noise properties von Junker, M., Ammann, M.J., Schwarzbacher, A.T., Klinger, J., Lauterbach, K.-U., Schneider, T.

Volltext

Could inequality in health be cured by universal coverage for all citizens? von Lungen, M., Siegel, M., Lauterbach, K. W.

Volltext

Adapting Brillouin spectrum for slow light delays von SCHNEIDER, Th, HENKER, R, LAUTERBACH, K.-U, JUNKER, M

Volltext

Group velocity dispersion reduction in fibre-based slow-light systems via stimulated Brillouin scattering von HENKER, R, WIATREK, A, LAUTERBACH, K.-U, AMMANN, M. J, SCHWARZBACHER, A. T, SCHNEIDER, T

Volltext

Cost-effectiveness of FDG-PET for the management of potentially operable non-small cell lung cancer: priority for a PET-based strategy after nodal-negative CT results von Dietlein, Markus, Weber, Kerstin, Gandjour, Afschin, Moka, Detlef, Theissen, Peter, Lauterbach, Karl W., Schicha, Harald

Volltext

European comparison of costs and quality in the treatment of acute myocardial infarction (2000–2001) von Gandjour, A., Kleinschmit, F., Lauterbach, K.W.

Volltext

Does prevention save costs? Considering deferral of the expensive last year of life von Gandjour, Afschin, Lauterbach, Karl Wilhelm

Volltext

Staatlich geprüfte Lebensmittelchemikerinnen und Lebensmittelchemiker – ein Plädoyer für das praktische Jahr und den öffentlichen Dienst von Bienzle, B., Eggen, A., Hegmanns, M., Geßener, C., Mainczyk‐Lauterbach, K., Riehle, J.

Volltext

European comparison of costs and quality in the prevention of secondary complications in Type 2 diabetes mellitus (2000-2001) von Gandjour, A., Kleinschmit, F., Lauterbach, K. W.

Volltext

Assessment of clinically silent atherosclerotic disease and established and novel risk factors for predicting myocardial infarction and cardiac death in healthy middle-aged subject... von Schmermund, Axel, Möhlenkamp, Stefan, Stang, Andreas, Grönemeyer, Dietrich, Seibel, Rainer, Hirche, Herbert, Mann, Klaus, Siffert, Winfried, Lauterbach, Karl, Siegrist, Johannes, Jöckel, Karl-Heinz, Erbel, Raimund

Volltext

Cost-Benefit Analysis of a Plant Sterol Containing Low-Fat Margarine for Cholesterol Reduction von Gerber, A., Evers, T., Haverkamp, H., Lauterbach, K. W.

Volltext

Cost-effectiveness of FDG-PET for the management of solitary pulmonary nodules: a decision analysis based on cost reimbursement in Germany von Dietlein, Markus, Weber, Kerstin, Gandjour, Afschin, Moka, Detlef, Theissen, Peter, Lauterbach, Karl W., Schicha, Harald

Volltext

Systematic review on the cost-effectiveness of public health interventions for HIV prevention in industrialized countries von Schrappe, M, Lauterbach, K

Volltext

When Is It Worth Introducing a Quality Improvement Program? A Mathematical Model von Gandjour, Afschin, Lauterbach, Karl Wilhelm

Volltext

Economic evaluation studies in nuclear medicine: the need for standardization von Dietlein, Markus, Lauterbach, Karl W., Schicha, Harald, Knapp, Wolfram H.

Volltext

Noncoronary Measures Enhance the Predictive Value of Cardiac CT Above Traditional Risk Factors and CAC Score in the General Population von Mahabadi, Amir A., MD, Lehmann, Nils, PhD, Möhlenkamp, Stefan, MD, Pundt, Noreen, PhD, Dykun, Iryna, MD, Roggenbuck, Ulla, Moebus, Susanne, PhD, Jöckel, Karl-Heinz, PhD, Erbel, Raimund, MD, Kälsch, Hagen

Volltext

Evidence-based medicine: why do opponents and proponents use the same arguments? von Gerber, A, Lauterbach, K W

Volltext